Proteasome Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)

0 avg rating
( 0 ratings by Goodreads )
 
9781588292506: Proteasome Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)
View all copies of this ISBN edition:
 
 

A panel of leading academic and pharmaceutical investigators takes stock of the remarkable work that has been accomplished to date with proteasome inhibitors in cancer, and examines emerging therapeutic possibilities. The topics range from a discussion of the chemistry and cell biology of the proteasome and the rationale for proteasome inhibitors in cancer to a review of current clinical trials underway. The discussion of rationales for testing proteasome inhibitors in cancer models covers the role of the proteasome in NF-kB activation, the combining of conventional chemotherapy and radiation with proteasome inhibition, notably PS-341, new proteasome methods of inhibiting viral maturation, and the role of protesome inhibition in the treatment of AIDS. The authors also document the development of bortezomib (Velcade™) in Phase I clinical trials and in a multicentered Phase II clinical trials in patients with relapsed and refractory myeloma.

"synopsis" may belong to another edition of this title.

From the Back Cover:

Immediately upon the discovery some ten years ago that inhibition of the proteasome in cultured cells, mostly of tumor origin, caused the programmed cell death machinery to ramp up, it became imperative to investigate proteasome inhibition as a possible treatment for human cancers. In Proteasome Inhibitors in Cancer Therapy, Julian Adams, the leader in developing the field, brings together a panel of highly experienced academic and pharmaceutical investigators to take stock of the remarkable work that has been accomplished to date, and examine emerging therapeutic possibilities for proteasome inhibitors in cancer. The topics range from a discussion of the chemistry and cell biology of the proteasome and the rationale for proteasome inhibitors in cancer to a review of current clinical trials underway. The discussion of the very empirical and practical development of rationales to test proteasome inhibitors in cancer models covers the role of the proteasome in NF-kB activation, the combining of conventional chemotherapy and radiation with proteasome inhibition, notably PS-341, new proteasome methods of inhibiting viral maturation, and the role of proteasome inhibition in the treatment of AIDS. The authors also document the development of bortezomib (Velcade™) through multicentered clinical trials in patients with relapsed and refractory myeloma to FDA approval, and describe how modern pharmacogenomic tools can be used to predict which patients will respond to such proteasome inhibitor therapy. Additional chapters on the proteasome's basic biochemistry review its mechanism in the cell cycle and apoptosis and suggest opportunities for using proteasome inhibitors to find additional medicinal targets.
Authoritative and illuminating, Proteasome Inhibitors in Cancer Therapy makes clear that proteasome inhibition should prove a fertile area for the many future discoveries that will provide relief of suffering and extend the quality of life of patients afflicted with cancer and other debilitating diseases.

Review:

"Authoritative and illuminating...." - Tumori

"About this title" may belong to another edition of this title.

Top Search Results from the AbeBooks Marketplace

1.

Published by Humana Press (2004)
ISBN 10: 1588292509 ISBN 13: 9781588292506
New Hardcover Quantity Available: 1
Seller:
Irish Booksellers
(Portland, ME, U.S.A.)
Rating
[?]

Book Description Humana Press, 2004. Condition: New. book. Seller Inventory # M1588292509

More information about this seller | Contact this seller

Buy New
US$ 89.38
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

2.

Adams, Julia
ISBN 10: 1588292509 ISBN 13: 9781588292506
New Quantity Available: 1
Seller:
Bookshub
(Karol Bagh, India)
Rating
[?]

Book Description Condition: New. New. US edition. Perfect condition. Customer satisfaction our priority. Seller Inventory # ABE-FEB-101226

More information about this seller | Contact this seller

Buy New
US$ 93.78
Convert Currency

Add to Basket

Shipping: FREE
From India to U.S.A.
Destination, Rates & Speeds

3.

Adams, Julia
ISBN 10: 1588292509 ISBN 13: 9781588292506
New Quantity Available: 1
Seller:
EBOOKSTORE2010
(New Delhi, ND, India)
Rating
[?]

Book Description Condition: Brand New. New. US edition. Customer Satisfaction guaranteed!!. Seller Inventory # SHUB101226

More information about this seller | Contact this seller

Buy New
US$ 93.83
Convert Currency

Add to Basket

Shipping: FREE
From India to U.S.A.
Destination, Rates & Speeds

4.

Adams, Julia
ISBN 10: 1588292509 ISBN 13: 9781588292506
New Quantity Available: 1
Seller:
Basi6 International
(Irving, TX, U.S.A.)
Rating
[?]

Book Description Condition: Brand New. New, US edition. Excellent Customer Service. Seller Inventory # ABEUSA-101226

More information about this seller | Contact this seller

Buy New
US$ 97.63
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

5.

Julian Adams (Editor)
Published by Humana Press (2004)
ISBN 10: 1588292509 ISBN 13: 9781588292506
New Hardcover Quantity Available: 1
Seller:
Ergodebooks
(RICHMOND, TX, U.S.A.)
Rating
[?]

Book Description Humana Press, 2004. Hardcover. Condition: New. 2004. Seller Inventory # DADAX1588292509

More information about this seller | Contact this seller

Buy New
US$ 124.78
Convert Currency

Add to Basket

Shipping: US$ 4.99
Within U.S.A.
Destination, Rates & Speeds

6.

Julian Adams
Published by Humana Press Inc. (2004)
ISBN 10: 1588292509 ISBN 13: 9781588292506
New Quantity Available: > 20
Print on Demand
Seller:
Pbshop
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description Humana Press Inc., 2004. HRD. Condition: New. New Book.Shipped from US within 10 to 14 business days.THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # IP-9781588292506

More information about this seller | Contact this seller

Buy New
US$ 247.52
Convert Currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, Rates & Speeds

7.

Adams, Julian
Published by Springer (2016)
ISBN 10: 1588292509 ISBN 13: 9781588292506
New Paperback Quantity Available: 1
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description Springer, 2016. Paperback. Condition: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Seller Inventory # ria9781588292506_lsuk

More information about this seller | Contact this seller

Buy New
US$ 253.65
Convert Currency

Add to Basket

Shipping: US$ 5.39
From United Kingdom to U.S.A.
Destination, Rates & Speeds

8.

Published by Humana Press Inc., United States (2004)
ISBN 10: 1588292509 ISBN 13: 9781588292506
New Hardcover Quantity Available: 10
Seller:
Book Depository hard to find
(London, United Kingdom)
Rating
[?]

Book Description Humana Press Inc., United States, 2004. Hardback. Condition: New. 2004 ed.. Language: English . This book usually ship within 10-15 business days and we will endeavor to dispatch orders quicker than this where possible. Brand New Book. A panel of leading academic and pharmaceutical investigators takes stock of the remarkable work that has been accomplished to date with proteasome inhibitors in cancer, and examines emerging therapeutic possibilities. The topics range from a discussion of the chemistry and cell biology of the proteasome and the rationale for proteasome inhibitors in cancer to a review of current clinical trials underway. The discussion of rationales for testing proteasome inhibitors in cancer models covers the role of the proteasome in NF-kB activation, the combining of conventional chemotherapy and radiation with proteasome inhibition, notably PS-341, new proteasome methods of inhibiting viral maturation, and the role of protesome inhibition in the treatment of AIDS. The authors also document the development of bortezomib (Velcade (TM)) in Phase I clinical trials and in a multicentered Phase II clinical trials in patients with relapsed and refractory myeloma. Seller Inventory # LIE9781588292506

More information about this seller | Contact this seller

Buy New
US$ 263.12
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

9.

Julian Adams
Published by Humana Press Inc. (2004)
ISBN 10: 1588292509 ISBN 13: 9781588292506
New Quantity Available: > 20
Print on Demand
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description Humana Press Inc., 2004. HRD. Condition: New. New Book. Delivered from our US warehouse in 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND.Established seller since 2000. Seller Inventory # IP-9781588292506

More information about this seller | Contact this seller

Buy New
US$ 258.23
Convert Currency

Add to Basket

Shipping: US$ 12.57
From United Kingdom to U.S.A.
Destination, Rates & Speeds

10.

JULIAN ADAMS
Published by Humana Press (2004)
ISBN 10: 1588292509 ISBN 13: 9781588292506
New Hardcover Quantity Available: 1
Seller:
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description Humana Press, 2004. Hardback. Condition: NEW. 9781588292506 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. For all enquiries, please contact Herb Tandree Philosophy Books directly - customer service is our primary goal. Seller Inventory # HTANDREE0306964

More information about this seller | Contact this seller

Buy New
US$ 290.41
Convert Currency

Add to Basket

Shipping: US$ 11.15
From United Kingdom to U.S.A.
Destination, Rates & Speeds

There are more copies of this book

View all search results for this book